Why the study?
The role of CMR in guiding coronary revascularisation based on myocardial viability remains debated, particularly after the REVIVED trial.
Does coronary revascularisation reduce all-cause mortality in patients with ischaemic cardiomyopathy and viable myocardium assessed by CMR LGE granularity?
Population
1,698 ICM patients with LVEF <50% and viable myocardium referred for CMR viability assessment
Comparison
Revascularisation within 90 days vs no revascularisation
Design
Retrospective analysis of a multicentre study
Follow-up
Median 8.9 years
Key result
Revascularisation in ischemic cardiomyopathy patients with viable myocardium reduced mortality by 72% (HR 0.28) over ~9 years, especially with moderate LGE extent and antero-septal LGE.
Authors
Loading...
Supports viability-guided revascularisation in ischaemic cardiomyopathy; extends observational data but leaves open RCT confirmation.
Does coronary revascularisation reduce all-cause mortality in patients with ischaemic cardiomyopathy and viable myocardium assessed by CMR LGE granularity?
CMR-guided coronary revascularisation based on LGE granularity is associated with improved long-term survival in ischaemic cardiomyopathy patients with viable myocardium, particularly those with moderate LGE extent and antero-septal distribution.
Unger et al. (2025) studied this question. Revascularisation in ischemic cardiomyopathy patients with viable myocardium reduced mortality by 72% (HR 0.28) over ~9 years, especially with moderate LGE extent and antero-septal LGE.